The company said the submission for the vaccine, branded as Spikevax, is based on guidance from the FDA, which advised that the shots should be updated to target strains that are a part of JN.1 ...

Moderna said on Friday it has filed a marketing application for the review of its updated COVID-19 vaccine with the U.S. Food ...

A new COVID variant, NB.1.8.1, linked to a surge in China, has been detected in the United States via international travelers ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...